Meito Co

Meito Co EBIT Growth

The Year-over-Year EBIT Growth of Meito Co (2207.T) as of Nov 18, 2026 is -3.98 %. In the previous year, Year-over-Year EBIT Growth was 506.03 % — a change of -100.79% (lower).

EBIT Growth

-3.98 %

YoY

-100.79%

Last updated:

Year-over-Year EBIT Growth of Meito Co is 2026 -3.98 % . Year-over-Year EBIT Growth of Meito Co was 2025 506.03 % . It decreases by -100.79% lower compared to the previous year.

The Meito Co EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2019
-77.48 JPY
Jan 1, 2020
287.08 JPY
Jan 1, 2021
-50.19 JPY
Jan 1, 2022
-13.15 JPY
Jan 1, 2023
-72.57 JPY
Jan 1, 2024
141.67 JPY
Jan 1, 2025
506.03 JPY
Jan 1, 2026
-3.98 JPY
The Meito Co EBIT Growth history
YEAREBIT GrowthYoY
-3.98 %-100.79%
506.03 %+257.20%
141.67 %-295.21%
-72.57 %+451.82%
-13.15 %-73.79%
-50.19 %-117.48%
287.08 %-470.53%
-77.48 %-216.32%
66.61 %+334.74%
15.32 %-94.23%
265.41 %+471.74%
46.42 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Meito Co Stock analysis

What does Meito Co do? Meito Sangyo Co., Ltd. generates revenue through three business segments. The Food segment sells chocolate, powdered beverages, baumkuchen, jelly, ice cream, candy, cakes, and nutritional foods. The Chemicals segment offers rennet, lipase, dextran, fragrance, dextran sulfate, dextran magnetite, mixed feed, and dextran iron. The Real Estate segment manages golf courses and leases real estate. Products are sold to consumers and businesses, with the Chemicals segment targeting medical and agricultural industries. The Food segment serves retail and food service markets, while Real Estate caters to leisure and commercial clients. The company's Food segment focuses on confectionery and dairy-related products like chocolate and ice cream, appealing to general consumers. Chemicals products such as rennet for cheese production and dextran sulfate for hyperlipidemia treatment are supplied to healthcare providers and animal health sectors. Real Estate management of golf courses and leasing services attract leisure enthusiasts and commercial tenants seeking property solutions. Meito Sangyo's product portfolio spans consumer goods, medical applications, and property management. The Food segment's nutritional foods and confectionery target health-conscious and casual consumers. Chemicals products like dextran magnetite for MRI contrast agents and dextran iron for animal drugs serve specialized medical and agricultural markets. Real Estate services provide recreational and commercial real estate solutions to diverse client segments. Meito Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meito Co stock

Year-over-Year EBIT Growth of Meito Co is -3.98 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Meito Co since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Meito Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Meito Co

All Key Metrics — Meito Co